MARK DONOWITZ, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD
License number
Maryland D02767
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-4166
(410) 955-9675
(410) 955-9675
Personal information
See more information about MARK DONOWITZ at radaris.comName
Address
Phone
4308 Greenway, Baltimore, MD 21218
Baltimore, MD
4308 Greenway, Baltimore, MD 21218
Organization information
See more information about MARK DONOWITZ at bizstanding.comMark Donowitz Medical Ofc At Johns
720 Rutland Ave #925, Baltimore, MD 21205
Categories:
Gastroenterology Physicians & Surgeons
Phone:
(410) 955-9675 (Phone)
Johns Hopkins Medical School - Mark Donowitz MD
720 Rutland Ave #925, Baltimore, MD 21205
Categories:
Medical Schools
Phone:
(410) 955-9675 (Phone)
Professional information
See more information about MARK DONOWITZ at trustoria.com
Dr. Mark Donowitz, Baltimore MD - MD (Doctor of Medicine)
Dr. Mark Donowitz, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
Johns Hopkins Univ/Divs GAS/HEP
720 Rutland Ave SUITE 925, Baltimore 21205
(410) 955-9675 (Phone)
720 Rutland Ave SUITE 925, Baltimore 21205
(410) 955-9675 (Phone)
Certifications:
Gastroenterology, 1975, Internal Medicine, 1972
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Johns Hopkins Univ/Divs GAS/HEP
720 Rutland Ave SUITE 925, Baltimore 21205
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
720 Rutland Ave SUITE 925, Baltimore 21205
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
Johns Hopkins University / School of Medicine
Graduated: 1968
The Johns Hopkins Hospital
Bronx Muni Hosps
Yale
Johns Hopkins University / School of Medicine
Graduated: 1968
The Johns Hopkins Hospital
Bronx Muni Hosps
Yale
Mark Donowitz, Baltimore MD
Mark Donowitz, Baltimore MD
Specialties:
Internal Medicine, Gastroenterology, Emergency Medicine
Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287 John Hopkins Medicine
2360 W Joppa Rd, Lutherville Timonium, MD 21093 Johns Hopkins University
720 Rutland Ave, Baltimore, MD 21205 John Hopkins Medicine
601 N Caroline St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287 John Hopkins Medicine
2360 W Joppa Rd, Lutherville Timonium, MD 21093 Johns Hopkins University
720 Rutland Ave, Baltimore, MD 21205 John Hopkins Medicine
601 N Caroline St, Baltimore, MD 21287
Education:
Johns Hopkins University (1968)
Mark Donowitz, Baltimore MD
Mark Donowitz, Baltimore MD
Specialties:
Gastroenterologist
Address:
720 Rutland Ave, Baltimore, MD 21205
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
Yale New Haven Psychiatric Hospital - Fellowship - Gastroenterology (Internal Medicine)
Yale New Haven Psychiatric Hospital - Fellowship - Gastroenterology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Human Nhe3 Protein And Non-Human Cells Expressing Same
Human Nhe3 Protein And Non-Human Cells Expressing Same
US Patent:
6392025, May 21, 2002
Filed:
Jun 15, 1998
Appl. No.:
09/097053
Inventors:
Steven R. Brant - Baltimore MD
C. H. Chris Yun - Timonium MD
Mark Donowitz - Baltimore MD
C. H. Chris Yun - Timonium MD
Mark Donowitz - Baltimore MD
Assignee:
Tranzmembrane, LLC - Reistertown MD
International Classification:
C07H 2104
US Classification:
536 235, 536 231, 435 6, 435 71, 435 691, 435325, 530350
Abstract:
This invention presents the cloning and characterization of human NHE3. It sets forth the entire coding region of the human NHE3 cDNA as well as the encoded protein, an 834 amino acid protein with a calculated relative molecular weight of 92,906.
Treatment Of Metastatic Colon Cancer With B-Subunit Of Shiga Toxin
Treatment Of Metastatic Colon Cancer With B-Subunit Of Shiga Toxin
US Patent:
7875586, Jan 25, 2011
Filed:
Dec 20, 2003
Appl. No.:
10/539212
Inventors:
Olga N. Kovbasnjuk - Ellicott City MD, US
Mark Donowitz - Baltimore MD, US
Mark Donowitz - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 38/00
US Classification:
514 12
Abstract:
The present invention relates to compositions and methods for treating invasive or metastatic cancer, particularly metastatic colon cancer using the B-submit of shiga toxin. The invention further provides methods of identifying compounds usefully for the treatment of invasive or metastatic cancer, particularly metastatic colon cancer.
Treatment Of Metastatic Colon Cancer With B-Subunit Of Shiga Toxin
Treatment Of Metastatic Colon Cancer With B-Subunit Of Shiga Toxin
US Patent:
2011020, Aug 18, 2011
Filed:
Jan 18, 2011
Appl. No.:
13/008681
Inventors:
Olga N. Kovbasnjuk - Ellicott City MD, US
Mark Donowitz - Baltimore MD, US
Mark Donowitz - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 38/16, A61P 35/00, C12Q 1/02, C12Q 1/68, G01N 33/92
US Classification:
514 193, 435 29, 435 613, 435 612, 435 792, 435 71
Abstract:
The present invention relates to compositions and methods for treating invasive or metastatic cancer, particularly metastatic colon cancer using the B-submit of shiga toxin. The invention further provides methods of identifying compounds usefully for the treatment of invasive or metastatic cancer, particularly metastatic colon cancer.
Method Of Identifying Agents That Affect Human Nhe3
Method Of Identifying Agents That Affect Human Nhe3
US Patent:
5871919, Feb 16, 1999
Filed:
Jul 10, 1996
Appl. No.:
8/677734
Inventors:
Steven R. Brant - Baltimore MD
Mark Donowitz - Baltimore MD
Chung-Ming Tse - Baltimore MD
Mark Donowitz - Baltimore MD
Chung-Ming Tse - Baltimore MD
International Classification:
C12Q 168, C12N 1512, C07K 14435
US Classification:
435 6
Abstract:
The present invention teaches a method of identifying agents that affect NHE3. Specifically, these methods comprise the steps of obtaining DNA encoding all or a portion of human NHE3, introducing that DNA into a recipient host cell whereby the host cell can perform Na+/H+ exchange, applying agents to the host cell, and assessing whether the agents affect Na+/H+ exchange.